Medisave Women Cancer Screening Package Advanced is a specialized preventive health package designed to help assess the risk of various cancers affecting women through advanced tumor marker evaluation.
This package includes 12 important cancer screening parameters that support early detection, monitoring, and risk assessment of ovarian cancer, breast cancer, gastrointestinal cancers, neuroendocrine tumors, thyroid-related malignancies, and other oncology conditions.
The profile is especially useful for women with:
- Family history of cancer
- Ovarian cancer risk factors
- Breast cancer concerns
- Unexplained weight loss
- Persistent abdominal symptoms
- Preventive health screening requirements
- Cancer treatment monitoring needs
Early screening can assist healthcare professionals in recommending further diagnostic evaluation when required.
🧪 TESTS INCLUDED IN THIS PACKAGE (12 TESTS)
🎗️ Cancer Markers
- CA 15.3
- CA 19.9
- Carcinoembryonic Antigen (CEA)
🧬 Tumor Marker
❤️ Cardiac & Tissue Damage Marker
- Lactate Dehydrogenase (LDH)
🦋 Thyroid Marker
👩 Women's Oncology Profile
- CA125
- Human Epididymis Protein 4 (HE4)
- ROMA Score – Premenopausal
- ROMA Score – Postmenopausal
🧫 Additional Tumor Markers
- Alpha Fetoprotein (AFP)
- Beta HCG
⭐ Key Benefits
- Comprehensive female cancer screening
- Ovarian cancer risk assessment
- Breast cancer marker evaluation
- Gastrointestinal cancer marker assessment
- Tumor marker monitoring
- Early detection support
- Women's preventive oncology screening
🏥 Recommended For
- Women above 30 years
- Women with family history of cancer
- Preventive health screening
- Ovarian cancer risk assessment
- Breast cancer monitoring
- Post-menopausal women
- High-risk oncology screening
⚠️ Important Information
- Fasting may be recommended for certain tests
- Blood sample collection required
- Home sample collection may be available
- Results should be interpreted by a qualified physician
- Tumor markers are screening and monitoring tools and are not standalone diagnostic tests
